Citation Impact
Citing Papers
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
A specific B2‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril
1992
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
Albuminuria in Mice after Injection of Antibodies against Aminopeptidase A
2001 StandoutNobel
Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells
1991
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Efficacy of low-dose spironolactone in subjects with resistant hypertension
2003
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
2003 StandoutNobel
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
2007 Standout
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
C‐Reactive Protein (CRP)‐Lowering Agents
2006
The Physiologic Basis of Diuretic Synergism: Its Role in Treating Diuretic Resistance
1991
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2‐terminal 20 peptide (PAMP)
2001
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.
1994 Standout
Gut microbiome and health: mechanistic insights
2022 Standout
Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
1992
Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitrostudies
1991
The L-Arginine-Nitric Oxide Pathway
1993 Standout
Importance of quantitative genetic variations in the etiology of hypertension
2000 StandoutNobel
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivostudies
1991 Standout
Interactions among ACE, kinins and NO
1999
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
2009 Standout
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor
1992 Standout
Angiotensin 11 Receptor Blockade and Effects on Pulmonary Hemodynamics and Hypoxic Pulmonary Vasoconstriction in Humans
1996
Chronic Kidney Disease
2016 Standout
A review of the medical treatment of primary aldosteronism
2001
Human genetics, animal models and computer simulations for studying hypertension☆
2004 StandoutNobel
Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
1992
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy
2002 StandoutNobel
Angiotensin Blockade Inhibits Activation of Mitogen-Activated Protein Kinases in Rat Balloon-Injured Artery
1998 StandoutNobel
Diabetes and Endothelial Dysfunction: A Clinical Perspective
2001
Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice
2008 Standout
Aberrant Renal Vascular Morphology and Renin Expression in Mutant Mice Lacking Angiotensin-Converting Enzyme
1997 StandoutNobel
Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
1992
Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor
2006
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
2001 StandoutNobel
Clinical pharmacology, physiology and pathophysiology of superficial veins‐2.
1994
Vasopeptidase Inhibition
2003
Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo
2007 StandoutNobel
ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models
2000
Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
1993
A genome-wide analysis of immune responses in Drosophila
2001 StandoutNobel
Bradykinin Antagonism Inhibits the Antigrowth Effect of Converting Enzyme Inhibition in the Dog Myocardium After Discrete Transmural Myocardial Necrosis
1995
Renal Hemodynamic Response to an Angiotensin II Antagonist, Eprosartan, in Healthy Men
1997
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease
2011
Angiotensin-Converting Enzyme Inhibitors
1998
A Mouse View of Hypertension
1997 StandoutNobel
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Captopril Suppression Versus Salt Loading in Confirming Primary Aldosteronism
2001
Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure
2001
Investigation of Chronic Venous Insufficiency
2000 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Gene Targeting Approaches to Analyzing Hypertension
1999 StandoutNobel
Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
1991
The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system
1990
Renal Kallikrein Excretion in Cirrhotics with Ascites: Relationship to Renal Hemodynamics†
1984
The Metabolic Syndrome
2008 Standout
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
2008
Renal growth and development in mice lacking AT1Areceptors for angiotensin II
1998 StandoutNobel
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Angiotensin-(1-7) Potentiates the Hypotensive Effect of Bradykinin in Conscious Rats
1995
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Flow-mediated endothelial mechanotransduction
1995 Standout
Recent developments in the design of angiotensin‐converting enzyme inhibitors
1985
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
1994
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Gerd Bönner being referenced
Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism
1990
Impact of acute and chronic sodium loading on atrial natriuretic peptide and renin in man
1989
ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases
1994
Interference of different ACE-inhibitors with the diuretic action of furosemide and hydrochlorothiazide
1989
The Role of Kinins in the Antihypertensive and Cardioprotective Effects of ACE Inhibitors
1997
Verbessert der Captopril-Test die Diagnostik des primären Hyperaldosteronismus?
2008
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: The VAST study
2005
Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
1993
Hemodynamic Effects of Bradykinin on Systemic and Pulmonary Circulation in Healthy and Hypertensive Humans
1990
Relationship between the renal kallikrein activity and the urinary excretion of kallikrein in rats
1982
Hemodynamic Effects of Bradykinin on Systemic and Pulmonary Circulation in Healthy and Hypertensive Humans
1990
Converting enzyme inhibition in kinin-deficient brown Norway rats.
1990
ACE inhibitor effect on bradykinin metabolism in the vascular wall.
1992
Renal Kallikrein Activity and Urinary Kallikrein Excretion in Rats with Experimental Renal Hypertension
1982
Spironolacton bei essentieller Hypertonie mit gestörter Aldosteron-Regulation und bei Conn-Syndrom
2008
Hyperinsulinemia, Insulin Resistance, and Hypertension
1994
Measurement of Kallikrein Activity in Urine of Rats and Man Using a Chromogenic Tripeptide Substrate. Validation of the Amidolytic Assay by Means of a Bradykinin Radioimmunoassay
1981
A Novel Orally Active Converting-Enzyme Inhibitor Ys 980: Effects on Blood Pressure in Spontaneously Hypertensive Rats
1979
Effect of Bradykinin on Arteries and Veins in Systemic and Pulmonary Circulation
1992
Natriuretic Action of ANP is Blunted by ACE Inhibition in Humans
1989